# Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

> **NCT00792766** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 20 (actual)

## Conditions studied

- Tuberous Sclerosis
- Angiolipoma

## Interventions

- **DRUG:** everolimus (RAD001)

## Key facts

- **NCT ID:** NCT00792766
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00792766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00792766, "Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00792766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*